Mettler-Toledo International Inc. (NYSE:MTD) Shares Sold by Flputnam Investment Management Co.

Flputnam Investment Management Co. lessened its holdings in Mettler-Toledo International Inc. (NYSE:MTD - Free Report) by 90.6% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 598 shares of the medical instruments supplier's stock after selling 5,794 shares during the period. Flputnam Investment Management Co.'s holdings in Mettler-Toledo International were worth $732,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of the business. Huntington National Bank lifted its stake in shares of Mettler-Toledo International by 20.0% in the 3rd quarter. Huntington National Bank now owns 54 shares of the medical instruments supplier's stock valued at $81,000 after purchasing an additional 9 shares during the last quarter. Townsquare Capital LLC lifted its stake in shares of Mettler-Toledo International by 2.0% in the 3rd quarter. Townsquare Capital LLC now owns 462 shares of the medical instruments supplier's stock valued at $693,000 after purchasing an additional 9 shares during the last quarter. M3 Advisory Group LLC lifted its stake in Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier's stock worth $202,000 after acquiring an additional 9 shares in the last quarter. Apollon Wealth Management LLC lifted its stake in Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier's stock worth $451,000 after acquiring an additional 9 shares in the last quarter. Finally, 1900 Wealth Management LLC lifted its stake in Mettler-Toledo International by 4.9% during the 4th quarter. 1900 Wealth Management LLC now owns 257 shares of the medical instruments supplier's stock worth $314,000 after acquiring an additional 12 shares in the last quarter. Institutional investors and hedge funds own 95.07% of the company's stock.

Remove Ads

Wall Street Analysts Forecast Growth

MTD has been the topic of several research reports. Wells Fargo & Company increased their target price on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the stock an "equal weight" rating in a research note on Monday, February 10th. Robert W. Baird increased their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a "neutral" rating in a research note on Monday, February 10th. Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an "outperform" rating in a research note on Monday, February 10th. Stifel Nicolaus decreased their target price on Mettler-Toledo International from $1,550.00 to $1,450.00 and set a "buy" rating on the stock in a research note on Monday, November 11th. Finally, Wolfe Research initiated coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a "peer perform" rating on the stock. One research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company's stock. According to MarketBeat, Mettler-Toledo International currently has a consensus rating of "Hold" and an average target price of $1,380.50.

Mettler-Toledo International Price Performance

Shares of MTD traded up $4.15 during mid-day trading on Thursday, reaching $1,261.99. The company's stock had a trading volume of 71,832 shares, compared to its average volume of 137,373. Mettler-Toledo International Inc. has a 12-month low of $1,142.91 and a 12-month high of $1,546.93. The stock has a market cap of $26.40 billion, a PE ratio of 31.14, a price-to-earnings-growth ratio of 3.30 and a beta of 1.13. The company's 50 day moving average is $1,292.06 and its 200 day moving average is $1,326.21.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings data on Thursday, February 13th. The medical instruments supplier reported $12.41 EPS for the quarter, beating analysts' consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. As a group, sell-side analysts anticipate that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insider Activity

In related news, insider Gerry Keller sold 600 shares of the company's stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the sale, the insider now directly owns 6 shares of the company's stock, valued at $8,108.04. This represents a 99.01 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Christian Magloth sold 790 shares of the company's stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the sale, the insider now directly owns 734 shares of the company's stock, valued at approximately $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.94% of the company's stock.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.